Hong Kong is.
Hong Kong is.
Hong Kong, Hong Kong1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma | Hepatitis B Virus Related Hepatocellular Carcinoma; Hepatocellular Carcinoma Recurrent | Recruiting | Phase 1 / Phase 2 | 2025-02-18 | NCT05417932 |